The complex pathophysiology of Trigeminal Autonomic Cephalalgias (TACs) involves a interplay between peripheral vascular structures, brainstem reflexes, and central hypothalamic regulation. To understand why TACs cause such intense, unilateral pain paired with autonomic signs, clinicians look at three core anatomical and physiological concepts: vascular theories, the trigeminal autonomic reflex, and central hypothalamic activation.
The classical vascular theory centers on neurogenic inflammation within the walls of the cavernous sinus. The cavernous sinus is the only anatomical region where trigeminal C-fibers and sympathetic nerves travel together. Inflammation or venous outflow obstruction in this region damages traversing sympathetic fibers along the internal carotid artery. This localized nerve compromise explains both the strict unilateral pain distribution and the ipsilateral sympathetic deficit symptoms, such as partial Horner's syndrome (ptosis and miosis) observed during attacks.
A second pivotal mechanism is the trigeminal autonomic reflex. Stimulation of trigeminal sensory afferent fibers in the face or cranium triggers a central reflex arch, leading to increased cranial parasympathetic outflow and reduced sympathetic drive. Parasympathetic activation accounts for symptoms such as lacrimation (tearing), conjunctival injection (redness), rhinorrhea (runny nose), and facial sweating. Simultaneously, impaired sympathetic tone manifests as eyelid drooping (ptosis) and pupil constriction (miosis).
Central control plays a dominant role in governing attack timing. Functional neuroimaging studies (such as PET scans) across all TACs demonstrate activation in the posterior hypothalamic area. The hypothalamus houses the biological clock, which explains key clinical characteristics of cluster headaches, such as seasonal periodicity, relapsing-remitting courses, and strict "clockwise" attack regularity occurring at predictable times during the day or night. Endocrine disruptions, including a blunted nocturnal melatonin peak, further validate central hypothalamic dysfunction in TAC pathophysiology.